401 related articles for article (PubMed ID: 38731563)
1. Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives.
Rehan F; Zhang M; Fang J; Greish K
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731563
[TBL] [Abstract][Full Text] [Related]
2. 2D materials-based nanomedicine: From discovery to applications.
Ouyang J; Rao S; Liu R; Wang L; Chen W; Tao W; Kong N
Adv Drug Deliv Rev; 2022 Jun; 185():114268. PubMed ID: 35398466
[TBL] [Abstract][Full Text] [Related]
3. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulating Nanomedicine for Cancer Therapy.
Liu Z; Jiang W; Nam J; Moon JJ; Kim BYS
Nano Lett; 2018 Nov; 18(11):6655-6659. PubMed ID: 30185039
[TBL] [Abstract][Full Text] [Related]
5. Nano based drug delivery systems: recent developments and future prospects.
Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
[TBL] [Abstract][Full Text] [Related]
6. Advances in intelligent DNA nanomachines for targeted cancer therapy.
Chen B; Mei L; Wang Y; Guo G
Drug Discov Today; 2021 Apr; 26(4):1018-1029. PubMed ID: 33217344
[TBL] [Abstract][Full Text] [Related]
7. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
[TBL] [Abstract][Full Text] [Related]
8. Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors.
Kim J; Cho H; Lim DK; Joo MK; Kim K
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373227
[TBL] [Abstract][Full Text] [Related]
9. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma.
Šamec N; Zottel A; Videtič Paska A; Jovčevska I
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979318
[TBL] [Abstract][Full Text] [Related]
11. Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies.
Li J; Wang Q; Han Y; Jiang L; Lu S; Wang B; Qian W; Zhu M; Huang H; Qian P
J Hematol Oncol; 2023 Jun; 16(1):65. PubMed ID: 37353849
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
Ma Y; Huang J; Song S; Chen H; Zhang Z
Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
[TBL] [Abstract][Full Text] [Related]
13. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
Danhier F
J Control Release; 2016 Dec; 244(Pt A):108-121. PubMed ID: 27871992
[TBL] [Abstract][Full Text] [Related]
14. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
[TBL] [Abstract][Full Text] [Related]
15. Nanotheranostics for personalized medicine.
Mura S; Couvreur P
Adv Drug Deliv Rev; 2012 Oct; 64(13):1394-416. PubMed ID: 22728642
[TBL] [Abstract][Full Text] [Related]
16. Cancer Nanomedicine: Lessons for Immuno-Oncology.
Sengupta S
Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
[TBL] [Abstract][Full Text] [Related]
17. Advances in engineering local drug delivery systems for cancer immunotherapy.
Abdou P; Wang Z; Chen Q; Chan A; Zhou DR; Gunadhi V; Gu Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1632. PubMed ID: 32255276
[TBL] [Abstract][Full Text] [Related]
18. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
19. Theranostic nanomedicine for cancer detection and treatment.
Fan Z; Fu PP; Yu H; Ray PC
J Food Drug Anal; 2014 Mar; 22(1):3-17. PubMed ID: 24673900
[TBL] [Abstract][Full Text] [Related]
20. The upcoming field of theranostic nanomedicine: an overview.
Prabhu P; Patravale V
J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]